Imidazoline2 (I2) binding site- and α2-adrenoceptor-mediated modulation of central noradrenergic and HPA axis function in control rats and chronically stressed rats with adjuvant-induced arthritis
- 29 April 2002
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 42 (7) , 958-965
- https://doi.org/10.1016/s0028-3908(02)00046-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Pharmacologic Characterization of Imidazoline Receptor Proteins Identified by Immunologic Techniques and Other MethodsaAnnals of the New York Academy of Sciences, 1999
- Effect of isolation-rearing on noradrenaline release in rat hypothalamus and hippocampus in vitroBrain Research, 1997
- Social isolation in the rat enhances α2-autoreceptor function in the hippocampus in vivoNeuroscience, 1997
- Evidence for Altered Control of Hypothalamic CRF in Immune‐Mediated DiseasesaAnnals of the New York Academy of Sciences, 1995
- Neurotransmitter Regulation of the Hypothalamic Corticotropin‐Releasing Hormone NeuronAnnals of the New York Academy of Sciences, 1995
- Psychoendocrinologic mechanisms of life stressStress Medicine, 1994
- ROLE OF CENTRAL CATECHOLAMINES IN THE MODULATION OF CORTICOTROPHIN-RELEASING FACTOR mRNA DURING ADJUVANT-INDUCED ARTHRITIS IN THE RATRheumatology, 1994
- Restraint-stress-induced changes in exploratory behavior appear to be mediated by norepinephrine-stimulated release of CRFJournal of Neuroscience, 1989
- Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamusJournal of Comparative Neurology, 1988
- Corticotropin releasing activity of the new CRF is potentiated several times by vasopressinNature, 1982